Nerve repair device house Orthocell is taking a cautious approach to entering the US market, with a staged approach to ...

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

EchoIQ’s heart-failure AI just hit Mayo’s testing track, chasing FDA clearance and a shot at fixing America’s $60bn hospital headache.

Golden Mile Resources (ASX:G88) goes over the first results from RC drilling in Arizona which showed plentiful copper and lead potential.